Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
about
2a967c01a90c7bf8d3971667c9f34a4bada7b2574a4f6d45463e83eaabaefae121cfa1fcb26cc5bf6fbc39b54d772e809e8d33a41e41a3cb80a0523e76012c1c030e0125d7433947dd8137b2698720fd90c1fedef450a0065f40e70f216d2ebaf4ac1dc7d6d030cc8ba1c933c0da239253ff9069b3d410c5e6921b999391a1d45003b7df84719cf67a931515eabdb356f149a1273c30cbb9f9237b911d95acd4eb2753beac41c6ad2727fe44e97a4fa0d058f9edee1805ae3d6caad8a13a8589aac7cc55539906e0ee94af1806e6f18a167d531e225824b40e5b35e6f147cef4dcdad973748bea8930eee5e003486394
P248
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
@ast
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
@en
type
label
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
@ast
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
@en
prefLabel
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
@ast
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
@en
P2093
P2860
P921
P356
P1433
P1476
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
@en
P2093
Jianmin Zhang
Peijun Liu
Pingping Li
P2860
P2888
P356
10.1038/SREP42125
P407
P577
2017-02-07T00:00:00Z
P6179
1083688646